IFRS 17 Risk Adjustment: Beyond the Number, It's About the Narrative

The arrival of IFRS 17 has pushed transparency in insurance reporting to the forefront. One of the most significant areas of judgment under the new standard is the Risk Adjustment (RA) for non-financial risk. This figure represents the compensation an insurer requires for bearing uncertainty. But IFRS 17 asks for more than just the final number; it demands that insurers 'show their work'. For finance leaders and executives, understanding these disclosure requirements is key to telling a credible and compelling story to the market.

The Core Disclosures: What You Must Reveal

IFRS 17 is explicit about what stakeholders need to see regarding your RA calculation. The goal is to allow users of financial statements to understand your approach to risk and the level of prudence embedded in your liabilities. The key disclosures required are:

1. The Method Used: You must clearly state the methodology chosen to estimate the RA. Whether you use a Cost of Capital (CoC) approach, a Value at Risk (VaR) or Conditional Tail Expectation (CTE) percentile method, or another technique, it must be named. This is the foundational piece of your disclosure narrative.

2. The Confidence Level: If your chosen method is based on a probability distribution (like VaR or CTE), you must disclose the corresponding confidence level. Stating you use a '75% VaR' is far more insightful than simply naming the method. This single number provides a quantifiable insight into your company's risk tolerance and the prudence of your estimate.

3. The Role of Diversification: Non-financial risks are rarely perfectly correlated. Insurers benefit from diversification across different lines of business or types of risk. IFRS 17 requires you to explain how you reflect these diversification benefits in your RA measurement. This is a critical area of judgment, and a clear explanation helps analysts understand the degree to which your overall RA is lower than the sum of its parts.

Why This Matters: From Compliance to Communication

These disclosures are not a simple box-ticking exercise. They serve a crucial purpose in building market confidence. By providing a clear line of sight into your RA calculation, you enable investors and analysts to:

Assess Comparability: While methods may differ between companies, transparent disclosures allow for more meaningful comparisons of risk appetite and balance sheet strength.

Understand Your Risk Profile: The choice of method and confidence level acts as a window into your management's view of risk. A higher confidence level, for instance, signals a more conservative stance.

Build Trust: In an area of high judgment, transparency is paramount. A well-articulated disclosure demonstrates robust governance and confidence in your actuarial and financial processes.

Crafting Your Narrative

Ultimately, the disclosure of your RA methods and assumptions should tell a coherent story. It should connect your technical choices to your business strategy and overall risk management framework. A high-quality disclosure moves beyond technical jargon to provide a clear, business-focused explanation that resonates with your stakeholders.

At Lux Actuaries, we believe that effective IFRS 17 reporting is about turning complexity into clarity. The Risk Adjustment disclosure is a prime opportunity to demonstrate the strength of your risk management and build lasting credibility with the market.